EP0149475B1 — Medicaments for the treatment and prevention of liver damage
Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1990-04-18 · 36y expired
What this patent protects
This invention concerns the novel use of nicardipine and pharmaceutically acceptable non-toxic salts thereof for the manufacture of medicaments for the treatment and prevention of liver damage induced by drugs, toxic chemicals, poisons, radiation, alcohol and viruses.
USPTO Abstract
This invention concerns the novel use of nicardipine and pharmaceutically acceptable non-toxic salts thereof for the manufacture of medicaments for the treatment and prevention of liver damage induced by drugs, toxic chemicals, poisons, radiation, alcohol and viruses.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.